Prostate cancer antigen 3 (PCA3) and microRNA-141 (miR-141) are emerging molecules in prostate cancer (PCa) pathogenesis and have been shown to be involvedin androgen signaling. This evidence concerns the gene PCA3 and posterior cortical atrophy.